会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 94. 发明申请
    • ELECTRICAL SKIN REJUVENATION
    • 电动皮肤护理
    • US20120041431A1
    • 2012-02-16
    • US13203436
    • 2010-02-22
    • Galit LevinZev Sohn
    • Galit LevinZev Sohn
    • A61B18/18
    • A61N1/40A61B18/14A61B2018/00452A61B2018/0047A61B2018/143A61N1/328
    • A method is provided for reducing a wrinkle on a skin surface (42). The method includes identifying a person having a skin surface (42) with a wrinkle and in response to identifying the person, positioning at respective sites on the skin surface (42) an array (44) of electrodes (60) coupled to an energy source (46). While the electrodes (60) are at the respective sites: during a first time period, applying energy from the energy source (46) to drive the electrodes (60) to apply radio frequency (RF) current at a first voltage, capable of ablating an epidermal layer of the skin; and during a second time period, applying energy from the energy source (46) to drive the electrodes (60) to apply current at a second voltage, lower than the first voltage. Other embodiments are also described.
    • 提供了一种用于减少皮肤表面(42)上的皱纹的方法。 该方法包括识别具有皱纹的皮肤表面(42)的人,并且响应于识别人,在皮肤表面(42)上的相应位置定位耦合到能量源的电极阵列(44) (46)。 当电极(60)处于相应位置时:在第一时间段期间,从能量源(46)施加能量以驱动电极(60)以在能够消融的第一电压处施加射频(RF)电流 表皮层皮肤; 并且在第二时间段期间,从能量源(46)施加能量以驱动电极(60)以比第一电压低的第二电压施加电流。 还描述了其它实施例。
    • 98. 发明申请
    • Handheld transdermal drug delivery and analyte extraction
    • 手持透皮药物递送和分析物提取
    • US20050119605A1
    • 2005-06-02
    • US10511966
    • 2004-12-30
    • Ze'ev Sohn
    • Ze'ev Sohn
    • A61B18/14A61B18/18A61N20060101A61N1/30A61N1/32
    • A61N1/327A61B18/14A61B2018/00208A61B2018/00452A61B2018/1467A61B2018/1861A61M37/00A61N1/0424A61N1/044A61N1/0476A61N1/306
    • Apparatus (20) for application to skin of a subject is provided. The apparatus includes a board (30) having a first surface and a second surface, the first surface including a plurality of ablation electrodes (41), which are adapted to be applied to the skin, and the second surface including one or more contact pads (32), each one of the contact pads electrically coupled to at least one of the ablation electrodes. The apparatus further includes one or more driving electrodes (28). An energy applicator (e.g., motor 22), coupled to the driving electrodes, is adapted to pass the driving electrodes over the contact pads. A power source (e.g., power unit 102) is adapted to drive a current from the driving electrodes, to the contact pads, and to the ablation electrodes. The current is capable of ablating at least a portion of stratum corneum of the skin in a vicinity of the ablation electrodes, so as to facilitate transdermal transport of a substance.
    • 提供了用于受试者皮肤的装置(20)。 所述装置包括具有第一表面和第二表面的板(30),所述第一表面包括适于施加到皮肤的多个消融电极(41),所述第二表面包括一个或多个接触垫 (32),所述接触垫中的每一个电耦合到所述消融电极中的至少一个。 该装置还包括一个或多个驱动电极(28)。 耦合到驱动电极的能量施加器(例如,马达22)适于使驱动电极穿过接触垫。 电源(例如,功率单元102)适于驱动来自驱动电极,接触焊盘和消融电极的电流。 该电流能够在消融电极附近烧蚀皮肤的角质层的至少一部分,以促进物质的透皮转运。
    • 99. 发明申请
    • TRANSDERMAL SYSTEM FOR EXTENDED DELIVERY OF INCRETINS AND INCRETN MIMETIC PEPTIDES
    • 用于延长递送和增加化学纤维素的变态系统
    • US20110129522A1
    • 2011-06-02
    • US13054908
    • 2009-07-21
    • Keren Mevorat-KaplanGalit LevinHagit SacksMeir Stern
    • Keren Mevorat-KaplanGalit LevinHagit SacksMeir Stern
    • A61K38/26A61K38/22A61K9/70A61P3/04A61P3/10
    • A61K9/7084A61K38/2278
    • A transdermal patch formulation of a viscous liquid that includes an active agent of incretin or incretin mimetic peptide, a stabilizer, a buffer, a water soluble thickening agent, and a pharmaceutically acceptable carrier. Also, a patch adapted for transdermal delivery of the active agent and having a drug reservoir compartment of the transdermal patch formulation and a system for facilitating transdermal delivery of the active agent through the skin of a subject. The system includes the patch and an apparatus capable of generating a plurality of micro-channels in an area on the subject's skin. The patch and apparatus are used in methods of treatment for reducing blood glucose level, lowering plasma glucagon levels, reducing food intake, or reducing gastric motility in a subject in need of the same by extending the release of the incretin or incretin mimetic peptide in the subject.
    • 粘性液体的透皮贴剂制剂,其包含肠降血糖素或模拟肽肠降胆固醇的活性剂,稳定剂,缓冲液,水溶性增稠剂和药学上可接受的载体。 而且,适于透皮递送活性剂并具有透皮贴剂制剂的药物储存室的贴剂以及促进活性剂通过受试者皮肤透皮递送的系统。 该系统包括贴片和能够在受试者皮肤上的区域中产生多个微通道的装置。 贴剂和装置用于治疗方法中,以降低血糖水平,降低血浆胰高血糖素水平,降低食物摄入量,或减少需要相同受试者的胃动力,从而延长肠内营养素或肠促胰岛素素模型肽的释放 学科。